Breast cancer treated at the University Hospital of Tromsø, Norway, 1986 to 94;Brystkreft behandlet ved Kreftavdelingen, Regionsykehuset i Tromsø 1986-94

Tidsskrift for den Norske Laegeforening

Volumn 117, Issue 26, 1997, Pages 3786-3789

  Norum, Jan ^a   Wist, Erik ^a  

^a Kreftavdelingen   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST TUMOR; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HUMAN; MASTECTOMY; METHODOLOGY; MIDDLE AGED; NORWAY; PROGNOSIS; QUALITY ADJUSTED LIFE YEAR; STATISTICS;

ADULT; AGED; BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MASTECTOMY; MASTECTOMY, MODIFIED RADICAL; MIDDLE AGED; NORWAY; PROGNOSIS; QUALITY-ADJUSTED LIFE YEARS;

EID: 0031591949     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Holte T, Hansen S, Næss Å, Parr E. Cancer in Norway 1993. Oslo: Kreftregisteret, Insitutt for epidemiologisk kreftforskning, 1996.
2. Norsk Brystkreft Gruppe. Brystkreft, diagnose og behandling. Oslo: Den Norske Kreftforening, 1994.
3. Norum J, Wist EA. Delay in diagnosis and treatment of breast cancer in northern Norway. Oncol Rep 1996; 3: 571-4.
4. Norum J. Postmastectomy radiotherapy, axillary lymph node dissection and oestrogen receptor status predict prognosis. Eur J Cancer 1995; 31: 1714.
5. Norum J. Breast conserving surgery (BCS) in northern Norway. Multicenter cooperative studies and treatment protocols ensure a high treatment standard. Int J Oncol 1996; 8: 633-7.
6. Norum J, Olsen JA, Wist EA. Lumpectomy or mastectomy? Is breast conserving surgery too expensive? Breast Cancer Res Treat 1997; 45: 7-14.
7. Holmberg L, Omne-Pontèn M, Burns T, Adams HO, Bergstrøm R. Psychosocial adjustment after mastectomy and breast-conserving treatment. Cancer 1989; 64: 969-74.
8. Williams A. EuroQol - a new facility for the measurement of health related quality of life. The EuroQol group. Health Policy 1990; 16: 199-208.
9. Katz SJ, Hislop TG, Thomas DB, Larson EB. Delay from symptom to diagnosis and treatment of breast cancer in Washington and British Colombia. Med Care 1993; 31: 264-8.
10. Månsson J, Bengtsson C. The diagnosis of breast cancer - experiences from the community of Kungsbacka, Sweden. Neoplasma 1992; 39: 305-8.
11. Marin I, Borras S. The role of radiotherapy in breast cancer, postoperative radiotherapy versus radiotherapy of the locoregional recurrences. Dis Abstr Int 1993; 54: 190.
12. Rose C, Thorpe SM, Anderson KW. Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high estrogen receptor values. Lancet 1985; 1: 16-9.
13. Rutquist LE, Cedermark B, Glas U. The Stockholm trial on adjuvant tamoxifen in early breast cancer. Correlation between estrogen receptor level and treatment effect. Breast Cancer Res Treat 1987; 10: 255-66.
14. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31000 recurrences and 24 000 deaths among 75 000 women. Lancet 1992; 339: 1-15, 71-85.
15. Kiricuta IC, Willner J, Kolbl O. The importance of axillary diagnosis in breast cancer from the viewpoint of radiotherapists. The results of a retrospective study of 671 patients. Strahlenther Onkol 1992; 168: 390-6.
16. Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Cancer 1992; 28: 1415-8.
17. Rossi S, Cinini C, DiPietro C, Lombardi CP, Crucitti A, Bellantone R et al. Diagnostic delay in breast cancer. Correlation with disease stage and prognosis. Tumori 1990; 76: 559-62.
18. Janjan NA, Murray KJ, Conway P, Walker A, Wilson F. Prognosis for breast cancer surgery and radiation therapy compared with mastectomy alone. A retrospective analysis of 759 patients with stage I/II breast cancer. Cancer 1992; 69: 2842-8.
19. Osborne MP, Ormiston N, Harmer CL. Breast concervation in the treatment of early breast cancer. A 20-year follow up. Cancer 1984; 53: 349-55.
20. For få kvinner tilbys brystbevarende kirurgi. Kreftforskning 1996; 6, nr. 8: 1.
21. Epstein RJ. Does the breast dollar make sense? Eur J Cancer 1992; 28: 486-91.
22. Norum J. Kan det komme noe godt fra DRG-systemet? Et redskap for helseøkonomiske analyser. Tidsskr Nor Lægeforen 1997; 117: 1500-2.